Two decades of soldiers’ medical records implicate common virus in multiple sclerosis

A new study links multiple sclerosis with Epstein-Barr virus, shown emerging from a B cell.STEVE GSCHMEISSNER/SCIENCE SOURCE https://www.science.org/content/article/two-decades-soldiers-medical-records-implicate-common-virus-multiple-sclerosis?utm_source=sfmc&utm_medium=email&utm_campaign=WeeklyLatestNews&utm_content=alert&et_rid=193273214&et_cid=4070142

Rate this:

Read Article →

New Synthetic Biomaterial Can Repair Hearts, Muscles, and Vocal Cords

Illustration shows the use of injectable hydrogel as an implant to fill a wound and to restore the voice. Credit: Sepideh Mohammadi https://scitechdaily.com/new-synthetic-biomaterial-can-repair-hearts-muscles-and-vocal-cords/?utm_source=TrendMD&utm_medium=cpc&utm_campaign=SciTechDaily_TrendMD_0

Rate this:

Read Article →

The Quad: UCLA researchers discuss stem cells, future of regenerative medicine

Stem cell research addresses a variety of medical needs. From bone strength to stroke studies, The Quad interviews UCLA frontiers in stem cell research. (Michael Vigman/Daily Bruin) https://dailybruin.com/2022/01/14/the-quad-ucla-researchers-discuss-stem-cells-future-of-regenerative-medicine

Rate this:

Read Article →

JPM 2022: Bristol Myers buoys cell therapy interests with $3B biobucks deal with Bayer-backed Century, $70M upfront to ArsenalBio

The two cell therapy deals, announced at J.P. Morgan Healthcare Conference, gives BMS access to natural killer cell and t-cell research in blood and solid tumors. (Bristol Myers Squibb) https://www.fiercebiotech.com/biotech/bristol-myers-signs-3b-biobucks-deal-century-for-cell-therapies-for-hematologic-solid

Rate this:

Read Article →